Ontology highlight
ABSTRACT:
SUBMITTER: Dahl ML
PROVIDER: S-EPMC4034010 | biostudies-literature | 2010 Mar
REPOSITORIES: biostudies-literature
Pharmaceuticals (Basel, Switzerland) 20100324 4
Increasing evidence for the role of pharmacogenetics in treatment resistance to the antiplatelet agent clopidogrel has been gained during the last years. Apart from <i>CYP2C19</i> genetic polymorphisms, nongenetic factors, particularly drug-drug interactions, age and other clinical characteristics influence the interindividual variability in clopidogrel response to varying degrees. The present article reviews the so far accumulated evidence on the role of pharmacogenetic traits influencing CYP-a ...[more]